Development of Carbon Monoxide Rebreathing to Estimate Blood Volume


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 14-006751
    Sponsor Protocol Number: 14-006751

About this study

The goal of the project is to develop and implement the optimized carbon monoxide rebreathing techniquein order to estimate blood volume.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Healthy normotensive male and non-pregnant female subjects between the ages of 18-80

Exclusion Criteria: 

  • Current smoker
  • Impaired respiratory function (COPD, asthma, etc.)
  • Cardiovascular/bleeding disorders
  • On any current medication (excluding birth control pills)

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Michael Joyner, M.D.

Open for enrollment

Contact information:

Shelly Roberts R.N.


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer